Theo Heller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Theo Heller has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Koh
Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
12 shared publications David Kleiner
8 shared publicationsPallavi Surana
6 shared publications- Devika Kapuria
Liver Diseases Branch NIDDK, NIH Bethesda Maryland USA
5 shared publications - Martha Quezado
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, USA
5 shared publications Anna Strongin
4 shared publications
Latest Publications
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-1087-1087
362 - Development of Non-Cirrhotic Portal Hypertension Increases Mortality Risk in at Risk Populations
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-1087-1087
362 - Development of Non-Cirrhotic Portal Hypertension Increases Mortality Risk in at Risk Populations
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Mo1889 - The Response to Vedolizumab in Chronic Granulomatous Disease
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Mo1889 - The Response to Vedolizumab in Chronic Granulomatous Disease
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-1209-1209
Mo1447 - Bile Duct Damage and Cirrhosis in Primary Biliary Cholangitis: An Investigation of Non-Invasive Biomarkers
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-1209-1209
Mo1447 - Bile Duct Damage and Cirrhosis in Primary Biliary Cholangitis: An Investigation of Non-Invasive Biomarkers
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Tu1539 - Vibration Controlled Elastography Predicts Severity of Portal Hypertension in Non Cirrhotic Portal Hypertension
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Tu1539 - Vibration Controlled Elastography Predicts Severity of Portal Hypertension in Non Cirrhotic Portal Hypertension
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-1216-1216
Mo1491 - Fibroscan in Sickle Cell Liver Disease-Could we Strike while the Liver is Hard?
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6) , S-1216-1216
Mo1491 - Fibroscan in Sickle Cell Liver Disease-Could we Strike while the Liver is Hard?
- 13 August 2017
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 37 (7) , 695-700
Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome
Objective STAT 3 deficiency (autosomal dominant hyper immunoglobulin E syndrome (AD-HIES)) is a primary immunodeficiency disorder with multi-organ involvement caused by dominant negative signal transducer and activator of transcription gene 3 (STAT3) mutations. We sought to describe the gastrointestinal (GI) manifestations of this disease. Methods Seventy subjects aged five to 60 years with a molecular diagnosis of AD-HIES were evaluated at the National Institutes of Health (NIH). Data collection involved a GI symptom questionnaire and retrospective chart review. Results In our cohort of 70 subjects, we found that 60% had GI symptoms (42/70). The most common manifestations were gastroesophageal reflux disease (GERD) observed in 41%, dysphagia in 31%, and abdominal pain in 24%. The most serious complications were food impaction in 13% and colonic perforation in 6%. Diffuse esophageal wall thickening in 74%, solid stool in the right colon in 50% (12/24), and hiatal hernia in 26% were the most prevalent radiologic findings. Esophagogastroduodenoscopy (EGD) demonstrated esophageal tortuosity in 35% (8/23), esophageal ulceration in 17% (4/23), esophageal strictures requiring dilation in 9% (2/23), and gastric ulceration in 17% (4/23). Esophageal eosinophilic infiltration was an unexpected histologic finding seen in 65% (11/17). Conclusion The majority of AD-HIES subjects develop GI manifestations as part of their disease. Most notable are the symptoms and radiologic findings of GI dysmotility, as well as significant eosinophilic infiltration, concerning for a secondary eosinophilic esophagitis. These findings suggest that the STAT3 pathway may be implicated in a new mechanism for the pathogenesis of several GI disorders.
- 13 August 2017
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 37 (7) , 695-700
Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome
Objective STAT 3 deficiency (autosomal dominant hyper immunoglobulin E syndrome (AD-HIES)) is a primary immunodeficiency disorder with multi-organ involvement caused by dominant negative signal transducer and activator of transcription gene 3 (STAT3) mutations. We sought to describe the gastrointestinal (GI) manifestations of this disease. Methods Seventy subjects aged five to 60 years with a molecular diagnosis of AD-HIES were evaluated at the National Institutes of Health (NIH). Data collection involved a GI symptom questionnaire and retrospective chart review. Results In our cohort of 70 subjects, we found that 60% had GI symptoms (42/70). The most common manifestations were gastroesophageal reflux disease (GERD) observed in 41%, dysphagia in 31%, and abdominal pain in 24%. The most serious complications were food impaction in 13% and colonic perforation in 6%. Diffuse esophageal wall thickening in 74%, solid stool in the right colon in 50% (12/24), and hiatal hernia in 26% were the most prevalent radiologic findings. Esophagogastroduodenoscopy (EGD) demonstrated esophageal tortuosity in 35% (8/23), esophageal ulceration in 17% (4/23), esophageal strictures requiring dilation in 9% (2/23), and gastric ulceration in 17% (4/23). Esophageal eosinophilic infiltration was an unexpected histologic finding seen in 65% (11/17). Conclusion The majority of AD-HIES subjects develop GI manifestations as part of their disease. Most notable are the symptoms and radiologic findings of GI dysmotility, as well as significant eosinophilic infiltration, concerning for a secondary eosinophilic esophagitis. These findings suggest that the STAT3 pathway may be implicated in a new mechanism for the pathogenesis of several GI disorders.